Health Catalyst, Inc. (HCAT)

Market Cap	270.75M
Revenue (ttm)	311.27M
Net Income (ttm)	-72.66M
Shares Out	69.60M
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	12.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	274,239
Open	3.940
Previous Close	3.990
Day's Range	3.880 - 3.990
52-Week Range	3.490 - 9.240
Beta	1.52
Analysts	Buy
Price Target	8.00 (+105.66%)
Earnings Date	Aug 6, 2025

About HCAT

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operat...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 25, 2019
• Employees: 1,500
• Stock Exchange: NASDAQ
• Ticker Symbol: HCAT
• Website: https://www.healthcatalyst.com

Financial Performance

In 2024, Health Catalyst's revenue was $306.58 million, an increase of 3.60% compared to the previous year's $295.94 million. Losses were -$69.50 million, -41.17% less than in 2023.

Analyst Summary

According to 11 analysts, the average rating for HCAT stock is "Buy." The 12-month stock price target is $8.0, which is an increase of 105.66% from the latest price.

Price Target

$8.0

(105.66% upside)

Analyst Consensus: Buy